<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Physiology and Pharmacology</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/06AE1AB5-19CE-44C1-A0AC-6B79EA4E75CD"><gtr:id>06AE1AB5-19CE-44C1-A0AC-6B79EA4E75CD</gtr:id><gtr:firstName>Sergey</gtr:firstName><gtr:surname>Kasparov</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D4A35CFA-4CB9-49E6-98BD-D7AF2EF68CD9"><gtr:id>D4A35CFA-4CB9-49E6-98BD-D7AF2EF68CD9</gtr:id><gtr:firstName>Anja Gabriele</gtr:firstName><gtr:surname>Teschemacher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FL019396%2F1"><gtr:id>60AC4860-85CC-4079-BC21-36CC73D5C2E7</gtr:id><gtr:title>Identification of the molecular substrate for L-lactate-mediated catecholamine signalling in the brain</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L019396/1</gtr:grantReference><gtr:abstractText>It is becoming evident that the function of the brain under normal and pathological conditions cannot be understood without taking into account the role of non-neuronal elements of this complex organ, numerous star-shaped cells known as astrocytes. The roles which astrocytes play in the brain are only currently emerging. It is established that these cells have a unique ability to store glucose in the form of glycogen and convert it into lactic acid (lactate) which they then release. Lactate for many years was thought to be used as an intermediate in the energy generating machinery of the body. However we have evidence that it has also another role in the brain where it acts as a transmitter or messenger between astrocytes and neurones. 
Using cutting edge technologies we have discovered that lactate can act on specific subsets of brain neurones which release a critical neurotransmitter and modulator, called noradrenaline. Action of lactate on these neurones excites them and makes them release more noradrenaline. This mechanism could be involved in many functions of the brain, including regulation of sleep-wake cycle, appetite, emotions, blood pressure, attention and others. This needs to be further investigated. Our research implies that there is a dedicated excitatory receptor for lactate in the brain and we aim to discover it in this project. We are therefore proposing a programme of research which will look for the candidate genes which could encode for this new receptor, verify its sensitivity to lactate and prove that it is able to confer sensitivity to lactate to neurones which are naturally not sensitive to lactate. These steps will form the basis for more in depth studies aimed at detailed characterisation of this novel mechanism and ultimately to the understanding of its role in health and disease. Without knowing the molecular identity of the lactate receptor further progress in this direction is essentially impossible. However, when we find the protein responsible for lactate effects we will be in a position to design drugs which act on this receptor and via this route potentially develop new therapies.</gtr:abstractText><gtr:technicalSummary>We have recently found that L-lactate (LL) acts as a powerful excitatory stimulus on central noradrenergic neurones, depolarising them and triggering release of noradrenaline. Interestingly, LL is not excitatory to non-noradrenergic neurones in the hippocampus. Our observations allow us to propose the existence of a yet unknown G-protein coupled receptor for LL which is coupled via Gs proteins to cAMP production. Importantly, the EC50 for this new receptor is ~0.5 mM which is within the physiological range of LL concentrations in the brain. Given the potency of this pathway, ubiquitous presence and prominent activity-dependent fluctuations of LL on the one hand, and the paramount role of noradrenergic transmission for the normal functioning of the brain on the other, this new signalling mechanism could be of major biological importance. We have performed an initial transcriptomic analysis of an LL-sensitive area and found a substantial number of currently orphan G-protein coupled receptors expressed. We hypothesise that the new LL receptor is one of them. The project involves a detailed and selective transcriptomic analysis of cells which are sensitive to LL in comparison with cells which are not; wide-scale screens of orphan GPCRs using a beta-arrestin assay; identification of the LL-sensitive receptors using a cAMP assay in cell lines; detailed characterisation of the pharmacological profile of the responses in the areas which we know to be LL sensitive in search of initial lead agonist and antagonist compounds; pharmacological analysis of any candidate receptors; and finally, an experiment where we will attempt to confer LL sensitivity to naturally LL insensitive neurones by expressing in them the newly identified putative target receptor. These studies will form the basis for further analysis of the physiology and pathophysiology associated with this signalling mechanism and for design of small molecule modulators which could have novel therapeutic properties.</gtr:technicalSummary><gtr:potentialImpactText>A novel receptor involved in fundamental adaptation of brain functions towards active states and autonomic regulation is likely to incite considerable interest in the public, research communities and pharmaceutical industry. In order to ensure the maximum impact of our findings, we will ensure dissemination of information to a range of relevant audiences:

Scientific audiences
 A new receptor with intriguing functional properties will answer some and open up a host of new scientific questions relevant to various fields of neuroscience and neuro-degeneration. We will address researchers by the well-established pathways of 
- Presentation of our work at conferences such as IUPS, Society of Neuroscience, Physiological Society, FENS, Gordon Conferences 
- Publication in high profile scientific media
- Engagement with young research audiences, including under- and postgraduate students in UK and internationally, for example Young Physiologists (UK) and Neuronus (international scientific youth conference).
- Training in multidisciplinary research skills such as use of viral vectors and optogenetics, in combination with confocal imaging and physiological experiments.

Public audiences
Since lactate is a generally well-known metabolite, findings that explain its central roles will attract interest of the public, creating opportunities to publically highlight issues surrounding healthy brain functions and age-dependent decline. In conjunction with scientific publication, we will 
- Prepare press releases in collaboration with the University of Bristol press office
- Publicize findings through websites such as the Bristol Neuroscience platform lectures

Pharmaceutical industry
The receptor which we are seeking is a potentially promising drug target to address health problems associated with a number of diseases with high potential for drug therapy. Drug industry will be informed of our work through 
- Our current collaborations with industrial partners at Novartis and GlaxoSmithKline with whom we communicate regularly
- Development of links with clinical research once the relevant protein has been identified
- Pathways that impact on the scientific community (see above) which may attract further interest from pharmaceutical industry. New contacts established in this way will be expanded and any potential patentable issues negotiated via the University of Bristol Research and Development department.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-09-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-09-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>492209</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Collaboration with Novartis (Basel) on the effect of L-lactate on GPR4 receptor</gtr:description><gtr:id>8088A2BF-7B17-46D7-BA01-4BDA9C6ECDFF</gtr:id><gtr:impact>Joint publication has been submitted, still in the stage of publishing.</gtr:impact><gtr:outcomeId>58c6b279163099.23774485-2</gtr:outcomeId><gtr:partnerContribution>Supervision of the student and organisation of several training and research trips to Novartis (Basel)</gtr:partnerContribution><gtr:piContribution>Collaboration was used to jointly supervise a student with a &amp;quot;year in industry&amp;quot; option. She performed experiments on a topic of mutual interest related to the theme of Lactate signalling.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Collaboration with Novartis (Basel) on the effect of L-lactate on GPR4 receptor</gtr:description><gtr:id>D56C8C24-79AF-45D4-988C-6A67A583F103</gtr:id><gtr:impact>Joint publication has been submitted, still in the stage of publishing.</gtr:impact><gtr:outcomeId>58c6b279163099.23774485-1</gtr:outcomeId><gtr:partnerContribution>Supervision of the student and organisation of several training and research trips to Novartis (Basel)</gtr:partnerContribution><gtr:piContribution>Collaboration was used to jointly supervise a student with a &amp;quot;year in industry&amp;quot; option. She performed experiments on a topic of mutual interest related to the theme of Lactate signalling.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited plenary lecture at 4th Winter seminar on Dementia (Italy) 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>674774B6-150B-4D69-B462-3087AAB328B9</gtr:id><gtr:impact>Invited lecture on technologies we use and our research</gtr:impact><gtr:outcomeId>58c6b699a3feb4.07331902</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Gordon conference 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8C9B5FEC-734B-4A5D-8971-EAD3A3013ABD</gtr:id><gtr:impact>Invited lecture at Gordon Research conference Angiotensin 2016 - Italy. Attended by key lab leaders around the world and a number of PhD students and young clinicians with various interests. Various discussions afterwards. Was also involved in poster ranking.</gtr:impact><gtr:outcomeId>56d6cb0451ff29.53765450</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.grc.org/programs.aspx?id=13998</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Volga Neuroscience conference 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>69073DA8-399B-4138-A0ED-45127EBEAE8A</gtr:id><gtr:impact>Two invited lectures were made and a poster presentation which was awarded as best presentation. Various collaborative projects were discussed.</gtr:impact><gtr:outcomeId>58c6b5c76b8834.14015110</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Demencia winter conference 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E0D22E93-D4DC-45E5-BE7C-75D3AABF3AF8</gtr:id><gtr:impact>Keynote speaker at the 4th Winter seminar on Dementia (Italy). Attended mainly by clinical scientists (~80 participants) involved in dementia research. Multiple discussions with participants and speakers.</gtr:impact><gtr:outcomeId>56d6c9d23d1ad2.75663438</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.sindem4juniors.it/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited presentation at Gordon Research conference, Ventura, CA 5-10 March 2017</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>41583005-30BA-4244-BE88-469CD58D2496</gtr:id><gtr:impact>GRC is the highest ranked international conference in the year. We presented our data there and this caused multiple discussions and sparked new collaborations.</gtr:impact><gtr:outcomeId>58c6b38c6174d4.42397918</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk at the 12 International Conference on Brain Energy and Metabolism, Hong Kong 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D40C7920-BF1D-4BC4-9EE7-C76A261EAD1F</gtr:id><gtr:impact>Lecture on the research related to our work for scientists, and local scientific media and local politicians.</gtr:impact><gtr:outcomeId>58c6b5333f6471.79298935</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at FENS 2016 meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>942A1144-3A9A-4BE0-8BD3-82D76EFFF065</gtr:id><gtr:impact>Poster presentation on our work which attracted a significant interest and led to development of the future research strategies.</gtr:impact><gtr:outcomeId>58c6b41dbcdfe7.61537817</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have discovered a potentially important effect of the signalling system under study for release of noradrenalin in the brain. We have established some characteristics of the putative receptor and obtained initial information about the structure-activity profile. We have also tested effect of lactate on a range of recombinant orphan receptors and made observations which should help to understand their function. This may lead to creation of new drugs. 
We have discovered a powerful modulatory action of L-lactate on one of the previously orphan receptors, paper is currently in the process of publication.
We have also identified some unusual receptors in the target area and are currently testing the effect of L-lactate on them in recombinant systems.
We have also found that there are olfactory receptors sensitive to L-lactate</gtr:description><gtr:exploitationPathways>We have only completed 1 full year and now all the methods are established. Potentially we might have discovered a new drug target but we need to do more work to better understand the practical applicability of the signalling system. 
We have also established methods for monitoring cAMP in various cellular system, including generation of vectors which can be used in vivo, this has never been done. 

Once the study is published this may be used as a basis for further analysis of the Lactate-mediated signalling in the brain and potentially lead to the development of new drugs.</gtr:exploitationPathways><gtr:id>B57CF495-58C2-4B20-BE91-09D59E3DB3C1</gtr:id><gtr:outcomeId>56c73fe1a30403.63558186</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Clones of various constructs distributed via AddGene (~40 over this period)</gtr:description><gtr:id>6F1BF721-246F-44C7-AB36-71764DC5FEB7</gtr:id><gtr:impact>Dozens of labs have been enabled to generate molecular constructs they require for various experiments. We also have shipped packaged viral vectors to 3 different Universities at no cost.</gtr:impact><gtr:outcomeId>56d6ccc2135420.07791167</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genetic constructs distribution</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>98261387-861D-4C5E-890F-D44B525AD913</gtr:id><gtr:title>Rodents and humans are able to detect the odour of L-Lactate.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9be455750e86eca14d4fd1cf3c85dc35"><gtr:id>9be455750e86eca14d4fd1cf3c85dc35</gtr:id><gtr:otherNames>Mosienko V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a2fcc3ea16dc0.21772714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE12FE82-FCAE-429E-9783-31D302A0C336</gtr:id><gtr:title>Vagal determinants of exercise capacity.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d34937cb92731fbd53ad8a7d016a3fe"><gtr:id>8d34937cb92731fbd53ad8a7d016a3fe</gtr:id><gtr:otherNames>Machhada A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a34f663c0f799.70469302</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DB536B0-82CF-4A32-875D-E33507AA2B73</gtr:id><gtr:title>Comparative analysis of optogenetic actuators in cultured astrocytes.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8671360143aa021f92db8c66abb36b2b"><gtr:id>8671360143aa021f92db8c66abb36b2b</gtr:id><gtr:otherNames>Figueiredo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn><gtr:outcomeId>doi_55f986986525e095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93EA050E-B4CF-4B4B-AA6F-6187E4959E76</gtr:id><gtr:title>ATP-mediated signaling plays key role in the generation of BOLD fMRI signal</gtr:title><gtr:parentPublicationTitle> International Society for Magnetic Resonance in Medicine, Milan 2014</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6bbd4831695403813266bb300e66303"><gtr:id>a6bbd4831695403813266bb300e66303</gtr:id><gtr:otherNames>Jack A Wells</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545b5b2aa55009.39270766</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D162F167-7E16-4373-9E84-4A94A74542EE</gtr:id><gtr:title>Lactate-mediated glia-neuronal signalling in the mammalian brain.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a232e0a3660b49b0d8b24aa6e95f94f"><gtr:id>3a232e0a3660b49b0d8b24aa6e95f94f</gtr:id><gtr:otherNames>Tang F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_540e194e194d3a679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFD0E573-7FA3-4A5C-A70C-E3C87C922184</gtr:id><gtr:title>Neuroprotective potential of astroglia.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4377ed4861af442d6d8939bfb897ce6"><gtr:id>a4377ed4861af442d6d8939bfb897ce6</gtr:id><gtr:otherNames>Liu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0360-4012</gtr:issn><gtr:outcomeId>5a2fcccc033ce7.91704025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA76B2D9-EB9B-4205-B5D1-8F1789CE68D3</gtr:id><gtr:title>A critical role for purinergic signalling in the mechanisms underlying generation of BOLD fMRI responses.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/910416dfe1e1fa70a891474bbc9375d7"><gtr:id>910416dfe1e1fa70a891474bbc9375d7</gtr:id><gtr:otherNames>Wells JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>56210b9adbf726.75108131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42F24705-7527-4EDE-B468-CF52DD424EFF</gtr:id><gtr:title>Release of ATP by pre-B&amp;ouml;tzinger complex astrocytes contributes to the hypoxic ventilatory response via a Ca-dependent P2Yreceptor mechanism.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a7d55cff12dafbf74a971a3722762d"><gtr:id>70a7d55cff12dafbf74a971a3722762d</gtr:id><gtr:otherNames>Rajani V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>5a2fcc3c8dffe7.94951576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBF97F12-449B-40D2-ADB9-19F30DFA362D</gtr:id><gtr:title>A sweet taste receptor-dependent mechanism of glucosensing in hypothalamic tanycytes.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1a5bddaaf10c82e0410f74e599a3853"><gtr:id>d1a5bddaaf10c82e0410f74e599a3853</gtr:id><gtr:otherNames>Benford H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>58c6bb86604f20.18784487</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE71E513-6E98-4F05-9266-CAC9FC617772</gtr:id><gtr:title>Ultrastructural Correlates of Enhanced Norepinephrine and Neuropeptide Y Cotransmission in the Spontaneously Hypertensive Rat Brain.</gtr:title><gtr:parentPublicationTitle>ASN neuro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe1e4a84dde83851353c0dabd1fe70b5"><gtr:id>fe1e4a84dde83851353c0dabd1fe70b5</gtr:id><gtr:otherNames>Kourtesis I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-0914</gtr:issn><gtr:outcomeId>56c738088019a1.42635204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>215DD7E9-B77E-42F8-A038-E093C4143183</gtr:id><gtr:title>Investigating the spatial linearity of the BOLD response using Opto-fMRI</gtr:title><gtr:parentPublicationTitle>British Chapter of the International Society for Magnetic Resonance in Medicine, Edinburgh 2014</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f107658d682701109ce77627a08a651"><gtr:id>8f107658d682701109ce77627a08a651</gtr:id><gtr:otherNames>Christie IN</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545b5c256af279.25010512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D09732F8-AA3C-496C-9CF1-26B1ECCB2728</gtr:id><gtr:title>Spatial Correlations of Neurovascular Coupling Studied Using Single-Pulse Opto-MRI</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9057da7a8f651bb320127050525ed48b"><gtr:id>9057da7a8f651bb320127050525ed48b</gtr:id><gtr:otherNames>Wells J.A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56210d4116fe13.30593321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF6EC5DF-6CC0-4D84-B824-920B2C757E8C</gtr:id><gtr:title>Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4377ed4861af442d6d8939bfb897ce6"><gtr:id>a4377ed4861af442d6d8939bfb897ce6</gtr:id><gtr:otherNames>Liu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>58ca6861040488.31636132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA6C8290-C368-446F-9742-F91E0BEBF8EF</gtr:id><gtr:title>Is L-lactate a novel signaling molecule in the brain?</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9be455750e86eca14d4fd1cf3c85dc35"><gtr:id>9be455750e86eca14d4fd1cf3c85dc35</gtr:id><gtr:otherNames>Mosienko V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>5675e36443ab3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2D5FEB2-4FBE-4CAD-ADF5-117F12DC184B</gtr:id><gtr:title>Volumetric Spatial Correlations of Neurovascular Coupling Studied using Single Pulse Opto-fMRI.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f107658d682701109ce77627a08a651"><gtr:id>8f107658d682701109ce77627a08a651</gtr:id><gtr:otherNames>Christie IN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c6bb5498ac83.30747454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEBCE30D-DCED-4160-AE29-7428D4544855</gtr:id><gtr:title>Current technical approaches to brain energy metabolism.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e333b4e38da9bc2e52d13373bda7e72"><gtr:id>1e333b4e38da9bc2e52d13373bda7e72</gtr:id><gtr:otherNames>Barros LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>5a2fcda07db240.22836025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97D7E393-2641-41EE-BFF0-36C2886F2FDC</gtr:id><gtr:title>Are Astrocytes the Pressure-Reservoirs of Lactate in the Brain?</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb029c53b496c5cfcede5d2368d412d0"><gtr:id>eb029c53b496c5cfcede5d2368d412d0</gtr:id><gtr:otherNames>Kasparov S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>56c737e12be3e6.02495538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEF188F6-C060-40D7-ABD6-2FE4B85189D8</gtr:id><gtr:title>Glia, sympathetic activity and cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Experimental physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d2a1cfb59235e7ed66e67e2290b933e"><gtr:id>1d2a1cfb59235e7ed66e67e2290b933e</gtr:id><gtr:otherNames>Marina N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0958-0670</gtr:issn><gtr:outcomeId>585d42bc280f40.45054525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>052BFC82-643F-4DB0-8F09-8239D5CD64BB</gtr:id><gtr:title>A Role for Astrocytes in Sensing the Brain Microenvironment and Neuro-Metabolic Integration.</gtr:title><gtr:parentPublicationTitle>Neurochemical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c1a57466ccaa395162d0ebf3d85a535"><gtr:id>9c1a57466ccaa395162d0ebf3d85a535</gtr:id><gtr:otherNames>Teschemacher AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-3190</gtr:issn><gtr:outcomeId>56e17c8ce2f7a5.81393927</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L019396/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>48D25546-6ADF-479A-8877-478CCDB1DC1F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Science</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>E793F7FE-614C-4A45-83A0-BE79B172092C</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal &amp; human physiology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>F439A20B-A9B0-4A68-B703-7F6AE7570E39</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Systems neuroscience</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>